Parexel to Get Phase I Unit in Purchase of California Clinical Trials
Waltham, Mass.-based Parexel, a global contract research organization (CRO), has agreed to acquire California Clinical Trials (CCT) and Behavioral and Medical Research (BMR) for $65 million. A key part of the deal is a 51-bed phase I unit that would boost Parexel's presence in the hot phase I market.
NIH Creates Academic Medical Center Consortium
The National Institutes of Health (NIH) has launched a new translational research consortium composed of some top academic medical centers (AMC) in the U.S.
Other breaking news...
VirtualScopics awarded contract... eClinicalWorks president and co-founder honored...
Company Profile: An interview with Ed Seguine, chief executive officer, Fast Track Systems
To read the full articles for this issue or for more information on these and other breaking stories, please click here!
